319 related articles for article (PubMed ID: 32678953)
21. Response to correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine.
De Stefano V; Candelli M; Rossi E; Franceschi F
Br J Haematol; 2021 Sep; 194(6):e95-e96. PubMed ID: 34170008
[No Abstract] [Full Text] [Related]
22. Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.
Fueyo-Rodriguez O; Valente-Acosta B; Jimenez-Soto R; Neme-Yunes Y; Inclán-Alarcón SI; Trejo-Gonzalez R; García-Salcido MÁ
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34059544
[TBL] [Abstract][Full Text] [Related]
23. Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases.
Taherifard E; Taherifard E; Movahed H; Mousavi MR
Hematology; 2021 Dec; 26(1):225-239. PubMed ID: 33594951
[TBL] [Abstract][Full Text] [Related]
24. Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic.
Pavord S; Thachil J; Hunt BJ; Murphy M; Lowe G; Laffan M; Makris M; Newland AC; Provan D; Grainger JD; Hill QA
Br J Haematol; 2020 Jun; 189(6):1038-1043. PubMed ID: 32374026
[TBL] [Abstract][Full Text] [Related]
25. Immune thrombocytopenic purpura secondary to SARS-CoV-2 infection in a child with acute lymphoblastic leukaemia: a case report and review of literature.
Dongre A; Jameel PZ; Deshmukh M; Bhandarkar S
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34740909
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatic Analysis Underpinning the Frequent Occurrence of Immune Thrombocytopenic Purpura in COVID-19 Patients.
Frankel AE; Wylie D; Peters B; Marrama D; Ahn C
Isr Med Assoc J; 2022 May; 24(5):320-326. PubMed ID: 35598057
[TBL] [Abstract][Full Text] [Related]
27. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).
Paulsen FO; Schaefers C; Langer F; Frenzel C; Wenzel U; Hengel FE; Bokemeyer C; Seidel C
Blood; 2021 Sep; 138(11):996-999. PubMed ID: 34297792
[No Abstract] [Full Text] [Related]
28. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
Lee EJ; Beltrami-Moreira M; Al-Samkari H; Cuker A; DiRaimo J; Gernsheimer T; Kruse A; Kessler C; Kruse C; Leavitt AD; Lee AI; Liebman HA; Newland AC; Ray AE; Tarantino MD; Thachil J; Kuter DJ; Cines DB; Bussel JB
Blood; 2022 Mar; 139(10):1564-1574. PubMed ID: 34587251
[TBL] [Abstract][Full Text] [Related]
29. Immune Thrombocytopenia and Cerebral Hemorrhaging Associated with COVID-19.
Hayashi K; Wada H; Shiraki K; Makino K
Intern Med; 2021 Nov; 60(21):3513. PubMed ID: 34471017
[No Abstract] [Full Text] [Related]
30. Immune thrombocytopenia and COVID-19: Case report and review of literature.
Alonso-Beato R; Morales-Ortega A; Fernández FJH; Morón AIP; Ríos-Fernández R; Rubio JLC; Centeno NO
Lupus; 2021 Aug; 30(9):1515-1521. PubMed ID: 34053365
[TBL] [Abstract][Full Text] [Related]
31. Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination.
Al-Ahmad M; Al Rasheed M; Shalaby N; Rodriguez-Bouza T; Altourah L
Clin Appl Thromb Hemost; 2022; 28():10760296211073920. PubMed ID: 35108113
[No Abstract] [Full Text] [Related]
32. COVID-19 as a cause of immune thrombocytopenia.
Humbert S; Razanamahery J; Payet-Revest C; Bouiller K; Chirouze C
Med Mal Infect; 2020 Aug; 50(5):459-460. PubMed ID: 32445664
[No Abstract] [Full Text] [Related]
33. Immune Thrombocytopenia (ITP) in a Pediatric Patient Positive for SARS-CoV-2.
Tsao HS; Chason HM; Fearon DM
Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32439817
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic approaches to secondary immune thrombocytopenic purpura.
Bussel JB
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S44-58. PubMed ID: 19245934
[TBL] [Abstract][Full Text] [Related]
35. A case of newly diagnosed immune thrombocytopenia in the COVID-19 era.
Clerici B; Birocchi S; Bertinato E; Di Benedetto C; Caberlon S; Cattaneo M; Podda GM
Intern Emerg Med; 2021 Nov; 16(8):2221-2225. PubMed ID: 33180223
[No Abstract] [Full Text] [Related]
36. Worsening of immune thrombocytopenic purpura in SARS-CoV-2 vaccinated patients.
García Ramírez P; Castilla García L; Aspa Cilleruelo JM
Med Clin (Barc); 2022 May; 158(10):497-498. PubMed ID: 34666903
[No Abstract] [Full Text] [Related]
37. Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT).
Parums DV
Med Sci Monit; 2021 Apr; 27():e932899. PubMed ID: 33900279
[TBL] [Abstract][Full Text] [Related]
38. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders.
Liebman HA
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S33-6. PubMed ID: 19245932
[TBL] [Abstract][Full Text] [Related]
39. Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis.
Artru F; Alberio L; Moradpour D; Stalder G
BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32641442
[TBL] [Abstract][Full Text] [Related]
40. Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination.
Saito K; Ichikawa S; Hatta S; Katsuoka Y; Harigae H; Izumi T
Ann Hematol; 2022 Apr; 101(4):885-887. PubMed ID: 34599382
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
